261 related articles for article (PubMed ID: 16305397)
1. Role of cyclodextrins in ophthalmics.
Kaur IP; Chhabra S; Aggarwal D
Curr Drug Deliv; 2004 Oct; 1(4):351-60. PubMed ID: 16305397
[TBL] [Abstract][Full Text] [Related]
2. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
[TBL] [Abstract][Full Text] [Related]
3. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
[TBL] [Abstract][Full Text] [Related]
4. Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.
Loftsson T; Stefánsson E
Acta Ophthalmol Scand; 2002 Apr; 80(2):144-50. PubMed ID: 11952479
[TBL] [Abstract][Full Text] [Related]
5. Cyclodextrins in drug delivery.
Loftsson T; Jarho P; Másson M; Järvinen T
Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
[TBL] [Abstract][Full Text] [Related]
6. Cyclodextrins in topical drug formulations: theory and practice.
Loftsson T; Masson M
Int J Pharm; 2001 Aug; 225(1-2):15-30. PubMed ID: 11489551
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
Jansook P; Pichayakorn W; Muankaew C; Loftsson T
Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786
[TBL] [Abstract][Full Text] [Related]
8. Analytical techniques for characterization of cyclodextrin complexes in aqueous solution: a review.
Mura P
J Pharm Biomed Anal; 2014 Dec; 101():238-50. PubMed ID: 24680374
[TBL] [Abstract][Full Text] [Related]
9. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.
Jóhannsdóttir S; Jansook P; Stefánsson E; Loftsson T
Int J Pharm; 2015 Sep; 493(1-2):86-95. PubMed ID: 26220650
[TBL] [Abstract][Full Text] [Related]
10. Beta-cyclodextrins as vehicles in eye-drop formulations: an evaluation of their effects on rabbit corneal epithelium.
Jansen T; Xhonneux B; Mesens J; Borgers M
Lens Eye Toxic Res; 1990; 7(3-4):459-68. PubMed ID: 2100172
[TBL] [Abstract][Full Text] [Related]
11. Considerations in the use of hydroxypropyl-beta-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone.
Bary AR; Tucker IG; Davies NM
Eur J Pharm Biopharm; 2000 Sep; 50(2):237-44. PubMed ID: 10962233
[TBL] [Abstract][Full Text] [Related]
12. Self-association of cyclodextrins and cyclodextrin complexes in aqueous solutions.
Loftsson T; Saokham P; Sá Couto AR
Int J Pharm; 2019 Apr; 560():228-234. PubMed ID: 30771468
[TBL] [Abstract][Full Text] [Related]
13. Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking.
Conde Penedo A; Díaz Tomé V; Fernández Ferreiro A; González Barcia M; Otero Espinar FJ
Eur J Pharm Biopharm; 2021 May; 162():12-22. PubMed ID: 33667681
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled cyclodextrin aggregates and nanoparticles.
Messner M; Kurkov SV; Jansook P; Loftsson T
Int J Pharm; 2010 Mar; 387(1-2):199-208. PubMed ID: 19963052
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans.
Kristinsson JK; Fridriksdóttir H; Thórisdóttir S; Sigurdardóttir AM; Stefánsson E; Loftsson T
Invest Ophthalmol Vis Sci; 1996 May; 37(6):1199-203. PubMed ID: 8631635
[TBL] [Abstract][Full Text] [Related]
16. Influence of hydroxypropyl beta-cyclodextrin on the corneal permeation of pilocarpine.
Aktaş Y; Unlü N; Orhan M; Irkeç M; Hincal AA
Drug Dev Ind Pharm; 2003 Feb; 29(2):223-30. PubMed ID: 12648019
[TBL] [Abstract][Full Text] [Related]
17. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
[TBL] [Abstract][Full Text] [Related]
18. Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea.
Okamoto N; Ito Y; Nagai N; Murao T; Takiguchi Y; Kurimoto T; Mimura O
J Oleo Sci; 2010; 59(8):423-30. PubMed ID: 20625234
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin containing biodegradable particles: from preparation to drug delivery applications.
Zafar N; Fessi H; Elaissari A
Int J Pharm; 2014 Jan; 461(1-2):351-66. PubMed ID: 24342710
[TBL] [Abstract][Full Text] [Related]
20. Supramolecular cyclodextrin complex: Diversity, safety, and applications in ocular therapeutics.
Chaudhari P; Ghate VM; Lewis SA
Exp Eye Res; 2019 Dec; 189():107829. PubMed ID: 31605685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
